ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0284

Nuclear Translocation of a Cleaved N-Terminal APOL1-G1 Fragment Drives Podocyte Toxicity in HIV-Associated Nephropathy

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Li, Jinliang, Children's National Hospital, Washington, District of Columbia, United States
  • Yu, Jing, University of Virginia, Charlottesville, Virginia, United States
  • Zhu, Junyi, University of Maryland Baltimore, Baltimore, Maryland, United States
  • Xu, Lian, Children's National Hospital, Washington, District of Columbia, United States
  • Das, Jharna R., Children's National Hospital, Washington, District of Columbia, United States
  • Han, Zhe, University of Maryland Baltimore, Baltimore, Maryland, United States
  • Ray, Patricio E., University of Virginia, Charlottesville, Virginia, United States
Background

APOL1-G1 risk variants increase susceptibility to HIV-associated nephropathy (HIVAN), but the mechanisms through which APOL1-G1 injures podocytes in the context of HIV-1 remain incompletely understood. Current models emphasize membrane-associated toxicity mediated by full-length APOL1 risk variants; however, inflammatory stress may also alter APOL1 localization, proteolytic processing, and downstream signaling. We hypothesized that HIV-1 and proinflammatory cytokines promote proteolytic processing of APOL1-G1, generating fragments capable of causing additional toxicity.

Methods

Podocytes cultured from the urine of children with HIVAN (HIVAN podocytes) were used to generate APOL1-G1/G1 and APOL1-knockout (KO) cell lines. Immunohistochemistry, qRT-PCR, bulk RNA-seq, proteomics, Western blotting, lipid raft isolation, and nuclear fractionation studies were performed. CRISPR-Cas9 editing was used to insert GFP in frame into exon 5 of endogenous APOL1-G1 to define its localization and cytotoxicity following exposure to HIV-1, TNF-α, and IFN-γ. In vivo toxicity was assessed using nephrocyte-specific expression of APOL1-G1 transgenes in Drosophila.

Results

Endogenous APOL1-G1 localized predominantly to a perinuclear endoplasmic reticulum-associated cytosolic compartment, lipid rafts, and vacuolar structures. HIV-1, TNF-α, and IFN-γ increased APOL1-G1 expression and cytotoxicity. APOL1-KO HIVAN podocytes were more permissive to HIV infection, suggesting a partial antiviral role for APOL1-G1. Unexpectedly, GFP-APOL1-G1 localized to the nuclei of select podocyte clones exhibiting enhanced inflammatory and cytotoxic transcriptional signatures. Proteomic analysis of nuclear fractions identified an N-terminal APOL1-G1 fragment (~14 kDa). Expression of either full-length APOL1-G1 fused to a nuclear localization signal or the N-terminal fragment markedly increased podocyte death. In vivo, nephrocyte-specific expression of GFP-APOL1-G1 significantly reduced nephrocyte survival.

Conclusion

These studies identify a previously unrecognized APOL1-G1 injury pathway in HIVAN podocytes in which proteolytic processing generates a toxic N-terminal fragment capable of nuclear accumulation. Our findings suggest that APOL1-G1–mediated podocyte injury involves both established membrane-associated toxicity and a distinct nuclear fragment–mediated cytotoxic pathway.

Funding

  • NIDDK Support